HepaCAM 通过 HIF-1α/NF-κB 通路调控肾细胞癌 Warburg 效应
该研究探讨肝细胞黏附分子(hepaCAM)如何经 HIF-1α 调控肾细胞癌(RCC)能量代谢。免疫组化显示 RCC 组织中 HIF-1α 表达升高、hepaCAM 受抑;hepaCAM 重新表达可降低 RCC 细胞系糖酵解代谢及 HIF-1α、IKKβ、P65 表达,并抑制 HIF-1α 转录活性、阻断 P65 核转位。结论提示 hepaCAM 经 HIF-1α/NF-κB 通路抑制 Warburg 效应。
要点
- RCC 组织中 HIF-1α 升高、hepaCAM 降低。
- hepaCAM 重新表达降低 RCC 细胞糖酵解及 HIF-1α、IKKβ、P65 表达。
- hepaCAM 抑制 HIF-1α 转录活性并阻断 P65 核转位。
核心结论
- hepaCAM 经 HIF-1α/NF-κB 通路抑制 RCC 的 Warburg 效应,可能是其减少肿瘤发生的促进因素。
研究设计与样本
- 基础实验研究:免疫组化检测 RCC 组织 hepaCAM 与 HIF-1α 表达,RCC 细胞系行糖代谢及信号通路检测。
主要发现
- 与癌旁正常组织相比,RCC 组织中 HIF-1α 表达升高、hepaCAM 受抑。
- hepaCAM 重新表达显著降低 RCC 细胞系糖酵解代谢,并减少 HIF-1α、IKKβ、P65 表达。
- hepaCAM 过表达联合 NF-κB 抑制剂 BAY11-7082 较单用 hepaCAM 过表达进一步降低 HIF-1α、GLUT1、LDHA、PKM2 表达。
- hepaCAM 降低 HIF-1α 转录活性,并经 NF-κB 通路阻断 P65 核转位。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate how hepatocyte cell adhesion molecule (hepaCAM) regulates cancer energy metabolism through hypoxia-inducible factor (HIF-1α) in renal cell carcinoma (RCC). MATERIALS AND METHODS: The expression of hepaCAM and HIF-1α in RCC tissue samples was examined by immunohistochemistry. Glucose consumption and lactate production assays were used to detect metabolic activity in RCC cell lines. P65 and IκB kinase (IKKβ) mRNA and protein expression were detected using quantitative real-time polymerase chain reaction and western blotting, respectively. Nuclear translocation of P65 was observed by immunofluorescence staining after re-expressing hepaCAM. The luciferase reporter assay was applied to validate the transcriptional activity of HIF-1α. RESULTS: HIF-1α expression was elevated and hepaCAM suppressed in RCC compared with adjacent normal tissues. Furthermore, hepaCAM re-expression significantly decreased glycolytic metabolism in RCC cell lines, and reduced HIF-1α, IKKβ, and P65 expression. The expression of HIF-1α, GLUT1, LDHA, and PKM2 were further reduced with combined hepaCAM overexpression and treatment with the NF-κB inhibitor BAY11-7082, compared to hepaCAM overexpression alone. Additionally, hepaCAM decreased the transcriptional activity of HIF-1α and blocked P65 nuclear translocation by the NF-κB pathway. CONCLUSION: Our data suggest that hepaCAM suppresses the Warburg effect via the HIF-1α/NF-κB pathway in RCC, which is a facilitating factor in hepaCAM-reduced tumorigenesis.
引用
- Fan Y, Ou L, Fan J, et al. HepaCAM Regulates Warburg Effect of Renal Cell Carcinoma via HIF-1α/NF-κB Signaling Pathway. Urology. 2018. PMID: 30528714. doi:10.1016/j.urology.2018.11.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。